What can we help you with today?
Filter by Topics
Filter by Category
Found 1599 results
Workspan Magazine
07/04/2022
Many employees feel pressure to be “all in” at their workplace and to keep up with internal competition, so they do not use their time off.
Author(s):
Workspan Daily
02/15/2024
For example, when sales slump and revenue drops, cost containment becomes a priority.
Author(s):
Workspan Daily
12/02/2022
Meanwhile, the retail sector saw 30,000 jobs lost, with employment in the trade dropping by 62,000 since August.
Workspan Daily
10/10/2025
Stay on top of hot total rewards/HR news by also reading: Federal News Roundup for Oct. 10, 2025; ADP: Private-Sector Job Creation Slow, Pay Up 4.5% YOY
Private-sector employers in the U.S. shed 32,000 jobs in September and pay to their workers was up 4.5% year-over-year, according to two reports released Oct. 1 by payroll services firm ADP.
Author(s):
Workspan Magazine
08/20/2021
While culture is certainly an organizational imperative, most employers intrigued by this model will need to take a brass-tacks approach by examining their compensation strategy as well as staying ahead of potential compliance hurdles.
Author(s):
Site Page
;Labor costs (Total Rewards) account for up to 70% of total business costs.
Workspan Daily
03/11/2026
As employers turn to more skills-based talent models, HR and TR leaders should rethink how rewards occur and how roles, including those considered “new-collar,” are structured and defined.
Author(s):
Workspan Daily
10/21/2022
Ultimately, whether employers opt for a hybrid model or full-time onsite schedule, flexibility in the approach is paramount for it to have the intended effect.
Author(s):
Workspan Daily
04/17/2025
.;
Using a bell-shaped distribution model, organizations can balance motivation and risk management, better ensuring that incentives reward strong performance without encouraging reckless decision-making.
Author(s):
Workspan Daily
11/10/2023
Prizer is cutting its workforce after slashing its guidance for the year by $9 billion, to between $58 billion and $61 billion, as sales of its COVID-19 vaccine dry up, the Journal reported.
